Bioprosthetic versus mechanical valves for mitral valve replacement in patients < 70 years: an updated pairwise meta-analysis

Background The ideal conduit for mitral valve replacement (MVR) remains elusive, particularly among younger patients due to increased life expectancy. We perform a pairwise meta-analysis comparing the use of bioprosthetic valves (BPV) and mechanical mitral valves (MMV) in patients 

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:General thoracic and cardiovascular surgery 2024-02, Vol.72 (2), p.95-103
Hauptverfasser: Ahmed, Adham, Awad, Ahmed K., Varghese, Kathryn S., Sehgal, Viren S., Hisham, Kenzy, George, Jerrin, Pandey, Roshan, Vega, Eamon, Polizzi, Mia, Mathew, Dave M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 103
container_issue 2
container_start_page 95
container_title General thoracic and cardiovascular surgery
container_volume 72
creator Ahmed, Adham
Awad, Ahmed K.
Varghese, Kathryn S.
Sehgal, Viren S.
Hisham, Kenzy
George, Jerrin
Pandey, Roshan
Vega, Eamon
Polizzi, Mia
Mathew, Dave M.
description Background The ideal conduit for mitral valve replacement (MVR) remains elusive, particularly among younger patients due to increased life expectancy. We perform a pairwise meta-analysis comparing the use of bioprosthetic valves (BPV) and mechanical mitral valves (MMV) in patients 
doi_str_mv 10.1007/s11748-023-01956-1
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2835273133</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2835273133</sourcerecordid><originalsourceid>FETCH-LOGICAL-c298t-d935d11bd5136ef0dec9f4c8271e580c6f9461b139dc8f82f363b2e585cd69193</originalsourceid><addsrcrecordid>eNp9kLtuFTEQhlcIRC7wAhTIJc0Gz3rttRENRFwiRUoDteVjzxJHe8PjPdHpEB1vkWfhUfIkGE6SkmI0I883v-Svql4APwHOu9cE0LW65o2oORipanhUHYJWolYdiMcPM5cH1RHRFedSaZBPqwPRtdCaDg6rn-_jvKSZ8iXm6NkWE63ERvSXboreDWzrhi0S6-fExpjT_QtLuAzO44hTZnFii8uxjHT749fbUh3_fbNDl-gNcxNbl-AyhgLFdB0JS352tZvcsKNIz6onvRsIn9_14-rrxw9fTj_X5xefzk7fnde-MTrXwQgZADZBglDY84De9K3XTQcoNfeqN62CDQgTvO510wslNk1ZSR-UASOOq1f73PLf7ytStmMkj8PgJpxXso0WsukECFHQZo_6ooYS9nZJcXRpZ4Hbv-7t3r0t7u0_9xbK0cu7_HUzYng4uZddALEHqKymb5js1bymYoH-F_sHuHmUPA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2835273133</pqid></control><display><type>article</type><title>Bioprosthetic versus mechanical valves for mitral valve replacement in patients &lt; 70 years: an updated pairwise meta-analysis</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>Ahmed, Adham ; Awad, Ahmed K. ; Varghese, Kathryn S. ; Sehgal, Viren S. ; Hisham, Kenzy ; George, Jerrin ; Pandey, Roshan ; Vega, Eamon ; Polizzi, Mia ; Mathew, Dave M.</creator><creatorcontrib>Ahmed, Adham ; Awad, Ahmed K. ; Varghese, Kathryn S. ; Sehgal, Viren S. ; Hisham, Kenzy ; George, Jerrin ; Pandey, Roshan ; Vega, Eamon ; Polizzi, Mia ; Mathew, Dave M.</creatorcontrib><description>Background The ideal conduit for mitral valve replacement (MVR) remains elusive, particularly among younger patients due to increased life expectancy. We perform a pairwise meta-analysis comparing the use of bioprosthetic valves (BPV) and mechanical mitral valves (MMV) in patients &lt; 70 years old undergoing MVR. Methods We comprehensively searched medical databases to identify studies comparing the use of BPV and MMV in patients &lt; 70 years old undergoing MVR. Pairwise meta-analysis was performed using the Mantel–Haenszel method in R version 4.0.2. Outcomes were pooled using the random effect model as risk ratios (RR) with their 95% confidence intervals (95% CI). Results 16,879 patients from 15 studies were pooled. Compared to MMV, BPV was associated with significantly higher rates of 30-day mortality (RR 1.53, p  = 0.0006) but no difference in 30-day stroke (RR 0.70, p  = 0.43). At a weighted mean follow-up duration of 14.1 years, BPV was associated with higher rates of long-term mortality (RR 1.28, p  = 0.0054). No difference was seen between the two groups for risk of long-term stroke (RR 0.92, p  = 0.67), reoperation(RR 1.72, p  = 0.12), or major-bleeding (RR 0.57, p  = 0.10) at a weighted mean follow-up duration of 11.7, 11.3, and 11.9 years, respectively. Conclusion The use of MMV in patients &lt; 70 undergoing MVR is associated with lower rates of 30-day/long-term mortality compared to BPV. No significant differences were observed for risk of 30-day/long-term stroke, long-term reoperation, and long-term major bleeding. These findings support the use of MMV in younger patients, although prospective, randomized trials are still needed.</description><identifier>ISSN: 1863-6705</identifier><identifier>EISSN: 1863-6713</identifier><identifier>DOI: 10.1007/s11748-023-01956-1</identifier><identifier>PMID: 37414971</identifier><language>eng</language><publisher>Singapore: Springer Nature Singapore</publisher><subject>Aged ; Aortic Valve - surgery ; Bioprosthesis - adverse effects ; Cardiac Surgery ; Cardiology ; Heart Valve Prosthesis - adverse effects ; Heart Valve Prosthesis Implantation - methods ; Hemorrhage - etiology ; Humans ; Medicine ; Medicine &amp; Public Health ; Mitral Valve - surgery ; Original Article ; Prospective Studies ; Reoperation ; Stroke - etiology ; Surgical Oncology ; Thoracic Surgery ; Treatment Outcome</subject><ispartof>General thoracic and cardiovascular surgery, 2024-02, Vol.72 (2), p.95-103</ispartof><rights>The Author(s), under exclusive licence to The Japanese Association for Thoracic Surgery 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><rights>2023. The Author(s), under exclusive licence to The Japanese Association for Thoracic Surgery.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c298t-d935d11bd5136ef0dec9f4c8271e580c6f9461b139dc8f82f363b2e585cd69193</cites><orcidid>0000-0002-8998-8267</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s11748-023-01956-1$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s11748-023-01956-1$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,778,782,27911,27912,41475,42544,51306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37414971$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ahmed, Adham</creatorcontrib><creatorcontrib>Awad, Ahmed K.</creatorcontrib><creatorcontrib>Varghese, Kathryn S.</creatorcontrib><creatorcontrib>Sehgal, Viren S.</creatorcontrib><creatorcontrib>Hisham, Kenzy</creatorcontrib><creatorcontrib>George, Jerrin</creatorcontrib><creatorcontrib>Pandey, Roshan</creatorcontrib><creatorcontrib>Vega, Eamon</creatorcontrib><creatorcontrib>Polizzi, Mia</creatorcontrib><creatorcontrib>Mathew, Dave M.</creatorcontrib><title>Bioprosthetic versus mechanical valves for mitral valve replacement in patients &lt; 70 years: an updated pairwise meta-analysis</title><title>General thoracic and cardiovascular surgery</title><addtitle>Gen Thorac Cardiovasc Surg</addtitle><addtitle>Gen Thorac Cardiovasc Surg</addtitle><description>Background The ideal conduit for mitral valve replacement (MVR) remains elusive, particularly among younger patients due to increased life expectancy. We perform a pairwise meta-analysis comparing the use of bioprosthetic valves (BPV) and mechanical mitral valves (MMV) in patients &lt; 70 years old undergoing MVR. Methods We comprehensively searched medical databases to identify studies comparing the use of BPV and MMV in patients &lt; 70 years old undergoing MVR. Pairwise meta-analysis was performed using the Mantel–Haenszel method in R version 4.0.2. Outcomes were pooled using the random effect model as risk ratios (RR) with their 95% confidence intervals (95% CI). Results 16,879 patients from 15 studies were pooled. Compared to MMV, BPV was associated with significantly higher rates of 30-day mortality (RR 1.53, p  = 0.0006) but no difference in 30-day stroke (RR 0.70, p  = 0.43). At a weighted mean follow-up duration of 14.1 years, BPV was associated with higher rates of long-term mortality (RR 1.28, p  = 0.0054). No difference was seen between the two groups for risk of long-term stroke (RR 0.92, p  = 0.67), reoperation(RR 1.72, p  = 0.12), or major-bleeding (RR 0.57, p  = 0.10) at a weighted mean follow-up duration of 11.7, 11.3, and 11.9 years, respectively. Conclusion The use of MMV in patients &lt; 70 undergoing MVR is associated with lower rates of 30-day/long-term mortality compared to BPV. No significant differences were observed for risk of 30-day/long-term stroke, long-term reoperation, and long-term major bleeding. These findings support the use of MMV in younger patients, although prospective, randomized trials are still needed.</description><subject>Aged</subject><subject>Aortic Valve - surgery</subject><subject>Bioprosthesis - adverse effects</subject><subject>Cardiac Surgery</subject><subject>Cardiology</subject><subject>Heart Valve Prosthesis - adverse effects</subject><subject>Heart Valve Prosthesis Implantation - methods</subject><subject>Hemorrhage - etiology</subject><subject>Humans</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Mitral Valve - surgery</subject><subject>Original Article</subject><subject>Prospective Studies</subject><subject>Reoperation</subject><subject>Stroke - etiology</subject><subject>Surgical Oncology</subject><subject>Thoracic Surgery</subject><subject>Treatment Outcome</subject><issn>1863-6705</issn><issn>1863-6713</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kLtuFTEQhlcIRC7wAhTIJc0Gz3rttRENRFwiRUoDteVjzxJHe8PjPdHpEB1vkWfhUfIkGE6SkmI0I883v-Svql4APwHOu9cE0LW65o2oORipanhUHYJWolYdiMcPM5cH1RHRFedSaZBPqwPRtdCaDg6rn-_jvKSZ8iXm6NkWE63ERvSXboreDWzrhi0S6-fExpjT_QtLuAzO44hTZnFii8uxjHT749fbUh3_fbNDl-gNcxNbl-AyhgLFdB0JS352tZvcsKNIz6onvRsIn9_14-rrxw9fTj_X5xefzk7fnde-MTrXwQgZADZBglDY84De9K3XTQcoNfeqN62CDQgTvO510wslNk1ZSR-UASOOq1f73PLf7ytStmMkj8PgJpxXso0WsukECFHQZo_6ooYS9nZJcXRpZ4Hbv-7t3r0t7u0_9xbK0cu7_HUzYng4uZddALEHqKymb5js1bymYoH-F_sHuHmUPA</recordid><startdate>20240201</startdate><enddate>20240201</enddate><creator>Ahmed, Adham</creator><creator>Awad, Ahmed K.</creator><creator>Varghese, Kathryn S.</creator><creator>Sehgal, Viren S.</creator><creator>Hisham, Kenzy</creator><creator>George, Jerrin</creator><creator>Pandey, Roshan</creator><creator>Vega, Eamon</creator><creator>Polizzi, Mia</creator><creator>Mathew, Dave M.</creator><general>Springer Nature Singapore</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-8998-8267</orcidid></search><sort><creationdate>20240201</creationdate><title>Bioprosthetic versus mechanical valves for mitral valve replacement in patients &lt; 70 years: an updated pairwise meta-analysis</title><author>Ahmed, Adham ; Awad, Ahmed K. ; Varghese, Kathryn S. ; Sehgal, Viren S. ; Hisham, Kenzy ; George, Jerrin ; Pandey, Roshan ; Vega, Eamon ; Polizzi, Mia ; Mathew, Dave M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c298t-d935d11bd5136ef0dec9f4c8271e580c6f9461b139dc8f82f363b2e585cd69193</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Aged</topic><topic>Aortic Valve - surgery</topic><topic>Bioprosthesis - adverse effects</topic><topic>Cardiac Surgery</topic><topic>Cardiology</topic><topic>Heart Valve Prosthesis - adverse effects</topic><topic>Heart Valve Prosthesis Implantation - methods</topic><topic>Hemorrhage - etiology</topic><topic>Humans</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Mitral Valve - surgery</topic><topic>Original Article</topic><topic>Prospective Studies</topic><topic>Reoperation</topic><topic>Stroke - etiology</topic><topic>Surgical Oncology</topic><topic>Thoracic Surgery</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ahmed, Adham</creatorcontrib><creatorcontrib>Awad, Ahmed K.</creatorcontrib><creatorcontrib>Varghese, Kathryn S.</creatorcontrib><creatorcontrib>Sehgal, Viren S.</creatorcontrib><creatorcontrib>Hisham, Kenzy</creatorcontrib><creatorcontrib>George, Jerrin</creatorcontrib><creatorcontrib>Pandey, Roshan</creatorcontrib><creatorcontrib>Vega, Eamon</creatorcontrib><creatorcontrib>Polizzi, Mia</creatorcontrib><creatorcontrib>Mathew, Dave M.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>General thoracic and cardiovascular surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ahmed, Adham</au><au>Awad, Ahmed K.</au><au>Varghese, Kathryn S.</au><au>Sehgal, Viren S.</au><au>Hisham, Kenzy</au><au>George, Jerrin</au><au>Pandey, Roshan</au><au>Vega, Eamon</au><au>Polizzi, Mia</au><au>Mathew, Dave M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Bioprosthetic versus mechanical valves for mitral valve replacement in patients &lt; 70 years: an updated pairwise meta-analysis</atitle><jtitle>General thoracic and cardiovascular surgery</jtitle><stitle>Gen Thorac Cardiovasc Surg</stitle><addtitle>Gen Thorac Cardiovasc Surg</addtitle><date>2024-02-01</date><risdate>2024</risdate><volume>72</volume><issue>2</issue><spage>95</spage><epage>103</epage><pages>95-103</pages><issn>1863-6705</issn><eissn>1863-6713</eissn><abstract>Background The ideal conduit for mitral valve replacement (MVR) remains elusive, particularly among younger patients due to increased life expectancy. We perform a pairwise meta-analysis comparing the use of bioprosthetic valves (BPV) and mechanical mitral valves (MMV) in patients &lt; 70 years old undergoing MVR. Methods We comprehensively searched medical databases to identify studies comparing the use of BPV and MMV in patients &lt; 70 years old undergoing MVR. Pairwise meta-analysis was performed using the Mantel–Haenszel method in R version 4.0.2. Outcomes were pooled using the random effect model as risk ratios (RR) with their 95% confidence intervals (95% CI). Results 16,879 patients from 15 studies were pooled. Compared to MMV, BPV was associated with significantly higher rates of 30-day mortality (RR 1.53, p  = 0.0006) but no difference in 30-day stroke (RR 0.70, p  = 0.43). At a weighted mean follow-up duration of 14.1 years, BPV was associated with higher rates of long-term mortality (RR 1.28, p  = 0.0054). No difference was seen between the two groups for risk of long-term stroke (RR 0.92, p  = 0.67), reoperation(RR 1.72, p  = 0.12), or major-bleeding (RR 0.57, p  = 0.10) at a weighted mean follow-up duration of 11.7, 11.3, and 11.9 years, respectively. Conclusion The use of MMV in patients &lt; 70 undergoing MVR is associated with lower rates of 30-day/long-term mortality compared to BPV. No significant differences were observed for risk of 30-day/long-term stroke, long-term reoperation, and long-term major bleeding. These findings support the use of MMV in younger patients, although prospective, randomized trials are still needed.</abstract><cop>Singapore</cop><pub>Springer Nature Singapore</pub><pmid>37414971</pmid><doi>10.1007/s11748-023-01956-1</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0002-8998-8267</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1863-6705
ispartof General thoracic and cardiovascular surgery, 2024-02, Vol.72 (2), p.95-103
issn 1863-6705
1863-6713
language eng
recordid cdi_proquest_miscellaneous_2835273133
source MEDLINE; Springer Nature - Complete Springer Journals
subjects Aged
Aortic Valve - surgery
Bioprosthesis - adverse effects
Cardiac Surgery
Cardiology
Heart Valve Prosthesis - adverse effects
Heart Valve Prosthesis Implantation - methods
Hemorrhage - etiology
Humans
Medicine
Medicine & Public Health
Mitral Valve - surgery
Original Article
Prospective Studies
Reoperation
Stroke - etiology
Surgical Oncology
Thoracic Surgery
Treatment Outcome
title Bioprosthetic versus mechanical valves for mitral valve replacement in patients < 70 years: an updated pairwise meta-analysis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T05%3A33%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Bioprosthetic%20versus%20mechanical%20valves%20for%20mitral%20valve%20replacement%20in%20patients%E2%80%89%3C%E2%80%8970%C2%A0years:%20an%20updated%20pairwise%20meta-analysis&rft.jtitle=General%20thoracic%20and%20cardiovascular%20surgery&rft.au=Ahmed,%20Adham&rft.date=2024-02-01&rft.volume=72&rft.issue=2&rft.spage=95&rft.epage=103&rft.pages=95-103&rft.issn=1863-6705&rft.eissn=1863-6713&rft_id=info:doi/10.1007/s11748-023-01956-1&rft_dat=%3Cproquest_cross%3E2835273133%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2835273133&rft_id=info:pmid/37414971&rfr_iscdi=true